The half-life of a drug eliminated by first-order elimination kinetics will be longer in individuals who have:

a) Increased volume of distribution or increased clearance
b) Increased volume of distribution or decreased clearance
c) Decreased volume of distribution or increased clearance
d) Decreased volume of distribution or decreased clearance